Filing Details

Accession Number:
0001181431-12-050158
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-12 17:49:56
Reporting Period:
2012-09-12
Filing Date:
2012-09-12
Accepted Time:
2012-09-12 17:49:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070336 Achillion Pharmaceuticals Inc ACHN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378586 Gautam Shah C/O Achillion Pharmaceuticals
300 George Street
New Haven CT 06511
Evp And Chief Compliance Ofc. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-09-12 3,875 $1.60 7,000 No 4 M Direct
Common Stock Acquisiton 2012-09-12 2,250 $1.60 9,250 No 4 M Direct
Common Stock Acquisiton 2012-09-12 5,125 $4.00 14,375 No 4 M Direct
Common Stock Disposition 2012-09-12 11,250 $8.00 3,125 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-09-12 3,875 $0.00 3,875 $1.60
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-09-12 2,250 $0.00 2,250 $1.60
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-09-12 5,125 $0.00 5,125 $4.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-09-12 No 4 M Direct
0 2012-09-12 No 4 M Direct
0 2012-09-12 No 4 M Direct
Footnotes
  1. This option was granted on May 26, 2004 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
  2. This option was granted on December 16, 2004 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
  3. This option was granted on December 20, 2005 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.